U.S. Paper and Forestry Products Stock News

In May 2026, Fairfax Financial’s Prem Watsa accumulated nearly 1.2 million Under Armour shares in structured blocks below US$5, coinciding with the company’s recent streak of four consecutive quarterly earnings beats and rapid international expansion. This combination of a high-profile value investor buying in size and management guiding to the first positive adjusted EPS in fiscal 2027 highlights growing confidence in Under Armour’s turnaround efforts despite ongoing North American weakness...

In its recent Q1 report, Black Stone Minerals posted EBITDA and EPS ahead of analyst forecasts while revenue came in below expectations. Despite the earnings beat on key profitability metrics, the company delivered the weakest performance versus analyst estimates among its peer group, highlighting investor sensitivity to revenue shortfalls. We’ll now examine how Black Stone Minerals’ mixed Q1 results, particularly the revenue shortfall, may reshape its existing investment...

COMPASS Pathways plc recently announced that Kathleen Tregoning has been elected to its Board of Directors, with plans for her to serve on both the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. Her background leading corporate affairs and commercial strategy at Cerevel Therapeutics, Sanofi and Biogen, combined with deep health policy experience in the U.S. Congress, adds industry, regulatory and commercialization expertise that could...

Recent performance snapshot HCI Group (HCI) has drawn investor attention after a mixed return profile, with the stock down over the past year and year to date, while still showing very large multiyear total returns. See our latest analysis for HCI Group. At a share price of $154.07, HCI’s short term momentum has cooled, with the 90 day share price return down 12.44% and the year to date share price return down 16.22%. However, the 3 year total shareholder return of 193.11% and 5 year total...

Immunocore Holdings recently reported updated Phase 1 results for its TCR bispecific brenetafusp in heavily pretreated HLA-A*02:01-positive advanced melanoma, showing a 6‑month overall survival rate of 87% and a disease control rate of 52%, and confirming 160 mcg as the dose for the ongoing Phase 3 PRISM-MEL-301 trial. This early signal of durable disease control in a difficult-to-treat melanoma population highlights how brenetafusp could broaden Immunocore’s oncology franchise beyond...

US Foods Holding stock overview after recent trading moves US Foods Holding (USFD) has drawn attention after a mixed stretch of returns, with the stock up over the past week but down around 12% over the past month and past 3 months. That performance sits alongside annual revenue of US$39.68b and net income of US$677m. These figures give investors concrete size and profitability markers as they assess whether recent share price moves align with the underlying business. See our latest analysis...

Hinge Health recently highlighted its progress since its May 2025 IPO, as CEO Daniel Perez discussed the company’s post-listing growth in a media interview alongside a pre-market update from the New York Stock Exchange trading floor. The CEO’s public focus on how the business has evolved since going public offers investors fresh insight into management priorities and execution. Against this backdrop, we’ll explore how CEO Daniel Perez’s post-IPO growth commentary may influence Hinge Health’s...

The Buckle, Inc. reported past first-quarter 2026 results with net sales rising to US$288.74 million and net income to US$46.88 million, lifting diluted earnings per share from continuing operations to US$0.92. Beyond higher sales, earnings were helped by a US$19.1 million interchange fee litigation settlement, while women’s and kids merchandise outperformed softer men’s denim and supported growth in comparable and online sales. Next, we’ll examine how Buckle’s stronger comparable store...

ASP Isotopes Inc. recently reported that it has successfully restarted the first 18 stages of its Silicon-28 enrichment facility in Pretoria, South Africa, following engineering upgrades to non-core components such as valves, compressors, and piping, after earlier shipping initial enriched Silicon-28 samples to a U.S. customer in 2025. This restart positions the company more firmly in supplying enriched Silicon-28, a material viewed as important for quantum computing progress and improving...

In May 2026, Vistance Networks announced that RUCKUS Networks and Fortis Solutions had completed a full Wi‑Fi 7 modernization of Oakland Arena in just 13 days, installing nearly 300 new access points and overhauling the routing and switching backbone. This rapid, automation‑enabled upgrade, which supported sold‑out events with very large data traffic and uninterrupted operations, highlights the scalability and real‑world performance of Vistance’s arena‑grade networking solutions. We’ll now...

Recent performance snapshot Hubbell (HUBB) has drawn investor attention after a period where the stock is down about 7% over the past month and roughly 3% over the past 3 months, despite a positive 1‑year total return. See our latest analysis for Hubbell. The recent share price pressure, with the stock down over the past month and quarter, contrasts with a stronger 1 year total shareholder return of about 26%. This suggests momentum has cooled after a solid multi year run. If you are watching...

The Morning Bull - US Market Morning Update Monday, Jun, 1 2026 US stock futures are pointing slightly higher this morning, with E mini S&P 500 contracts up about 0.2% and Nasdaq 100 futures ahead roughly 0.3%, as investors balance strong US data, calmer inflation signals, and mixed news from China. The Chicago PMI, a key scorecard of business activity in the Midwest, jumped to 62.7 in May 2026, which hints that companies are busier and could keep profits supported. At the same time, the 10...

PVH Corp. recently announced a series of leadership changes, including promoting Adelyn Cheong to CEO of PVH Americas, creating a new President of Global Licensing, Partnerships and Expansion role for Joel Samaha, and broadening Jonathan Bottomley’s remit to EVP, Group Consumer & Brand Strategy, with additional adjustments in its China leadership structure. Together, these moves signal a sharper emphasis on consumer insights, licensing and partnerships, and regional execution for Calvin...

Western Digital recently integrated post-quantum cryptography into its new Ultrastar UltraSMR hard drives and added former NVIDIA, Dell EMC, and Microsoft executive Manuvir Das to its board, strengthening its focus on secure, AI-era storage infrastructure. By hardening device-level trust with quantum-resistant security and bringing in deep enterprise AI expertise at the board level, Western Digital is aligning its product roadmap and governance with long-lived data protection needs for...

Why Pennant Group stock is drawing attention now Pennant Group (PNTG) is back on many watchlists after recent trading that leaves the stock with a market value of about US$1.19b and a last close of US$34.25. For investors tracking healthcare services, the company’s mix of home health, hospice, and senior living operations, along with its recent month and past 3 months returns, is giving fresh context to how the stock is currently priced. See our latest analysis for Pennant Group. Short term,...

In late May 2026, Roku rolled out a revamped, more personalized Home Screen to over 100 million streaming households and added FOX One as a premium subscription on The Roku Channel in the U.S., offering bundled access to FOX news, sports, entertainment, and all FIFA World Cup 2026 matches. Together, these moves deepen Roku’s role as a content-discovery and subscription hub, potentially increasing user engagement while making its platform more valuable to media and advertising partners. Next,...

In late May 2026, Veeva Systems announced several wins, including Kindeva Drug Delivery adopting Veeva Quality Cloud and global Veeva Vault CRM commitments from Merck KGaA and Teva Pharmaceuticals to modernize quality and commercial operations. These deals highlight how Veeva is embedding its cloud and AI-driven platforms deeper into life sciences workflows, spanning manufacturing, R&D, and commercial execution. Next, we'll examine how Veeva's expanding enterprise footprint, particularly...

Cogent Communications Holdings (CCOI) has drawn investor attention after the stock fell about 10% in the latest session and is now down roughly 23% over the past month. See our latest analysis for Cogent Communications Holdings. The recent slide builds on a weaker trend, with the share price down over the past quarter and the 1 year total shareholder return also declining sharply. This suggests sentiment has cooled and investors may be reassessing Cogent Communications Holdings' risk and...

In late May 2026, CNBC’s Jim Cramer highlighted SELLAS Life Sciences Group on “Mad Money,” calling the biotech a “great spec” and giving it “two thumbs up,” while investors tracked progress in its Phase 3 REGAL trial for GPS in AML patients in remission but ineligible for stem cell transplant. Attention is also building around SELLAS’ second AML candidate, SLS009, with upcoming topline data viewed as a potentially important catalyst for the company’s development pipeline. With recent returns...

In late May 2026, ZenaTech announced the early-stage development of ZenaWorx, a LiDAR-based virtual design and construction progress monitoring software that combines its Drone as a Service and Enterprise SaaS capabilities to support large-scale AI data center projects. By using drone-captured LiDAR to generate detailed 3D site maps and standardized analytics, ZenaWorx aims to become a core digital layer for tracking construction performance and design deviations across complex builds. We’ll...

Recent commentary on Proto Labs highlights muted revenue growth and falling earnings per share over recent years, raising questions about the company’s demand trends and profitability as of early 2026. Analysts are increasingly focused on Proto Labs’ below-average returns on capital and relatively high valuation multiple, which together suggest the market is paying a premium despite these operational headwinds. Next, we’ll examine how concerns over muted revenue growth and declining earnings...

In late May 2026, ICON plc reported full-year 2025 results showing sales of US$8.25 billion, a sharp drop in net income to US$229.34 million, disclosed multi-year revenue recognition issues, completed a US$750.01 million buyback program, updated 2026 revenue guidance to US$7.85–8.15 billion, and announced several board changes. While ICON is working through accounting control weaknesses and lower profitability, management highlighted strong Q4 2025 net bookings growth, a focus on...

Recent share performance and why investors are watching Parker-Hannifin Parker-Hannifin (PH) has drawn investor attention after a period of softer share performance, with the stock down over the past day, week, month, and three months, prompting fresh questions about how its fundamentals line up. See our latest analysis for Parker-Hannifin. Looking beyond the recent pullback, with the 90 day share price return down 14.57%, Parker-Hannifin’s 1 year total shareholder return of 29.03% and 3 year...

Recent price action and context Arcosa (ACA) has drawn fresh attention after recent trading saw the stock close at $126.75, with short term returns around 5% over the past week and mid single digit gains over the past month. See our latest analysis for Arcosa. That recent 5% 7 day share price return sits within a stronger run, with the share price up 14.9% over 90 days and year to date gains of 18.7%. The 1 year total shareholder return of 47.1% points to momentum that has been building...